Table 1 Baseline characteristics of the treated attacks
Characteristic | 1st attack in the run-in phase | 2nd attack in the run-in phasea | Training treatment | Test treatment |
|---|---|---|---|---|
Baseline pain severity, % (n/N) | ||||
Mild | 46.5% (46/99) | 33.3% (33/98) | 54.5% (54/99) | 35.4% (35/99) |
Moderate | 49.5% (49/99) | 49.5% (49/98) | 40.4% (40/99) | 57.6% (57/99) |
Severe | 4.0% (4/99) | 16.2% (16/98) | 5.1% (5/99) | 7.1% (7/99) |
Presence of baseline associated symptoms, % (n/N) | ||||
Nausea | 14.1% (14/99) | 29.3% (29/98) | 24.2% (24/99) | 25.3% (25/99) |
Photophobia | 64.6% (64/99) | 72.7% (72/98) | 64.6% (64/99) | 63.6% (63/99) |
Phonophobia | 61.6% (61/99) | 58.6% (58/98) | 50.5% (50/99) | 55.6% (55/99) |